Cargando…
Keep your eyes on the prize: Tackling breakthrough COVID-19 in MS patients
Autores principales: | van Kempen, Zoé LE, Killestein, Joep, Hartung, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597192/ https://www.ncbi.nlm.nih.gov/pubmed/34783282 http://dx.doi.org/10.1177/13524585211057511 |
Ejemplares similares
-
Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab
por: van Kempen, Zoé L.E., et al.
Publicado: (2022) -
Persistent Hypoxemia in COVID-19 Patients on ECMO: Keep Your Eyes on the Prize
por: Kopanczyk, Rafal, et al.
Publicado: (2022) -
Response to “Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing”
por: van Kempen, Zoé LE, et al.
Publicado: (2017) -
Emerging safety issues in alemtuzumab-treated MS
patients
por: Killestein, Joep, et al.
Publicado: (2019) -
Keeping an eye on Ca(2+) signalling to tackle dry eye diseases
por: Sneyers, Flore, et al.
Publicado: (2021)